
CREO MEDICAL GROUP PLC
CREO | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPQYW715 (+2 more)
- LEI:
- 213800H188ZDCWWXFA21
- Country:
- United Kingdom
- Address:
- CREO HOUSE UNIT 2, NP16 5UH CHEPSTOW
- Website:
- https://www.creomedical.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Creo Medical Group PLC is a medical device company focused on the development and commercialization of minimally invasive electrosurgical devices for the field of therapeutic endoscopy. The company's core technology is a proprietary advanced energy platform that uniquely combines bipolar radiofrequency for precise cutting and microwave energy for controlled coagulation. This platform powers a suite of devices, including its flagship Speedboat product, which is utilized in procedures such as Submucosal Dissection (SSD). By enabling complex procedures to be performed endoscopically, Creo Medical aims to improve patient outcomes, reduce healthcare costs, and provide alternatives to traditional surgery. The company supports clinicians through its comprehensive 'Pioneer' clinical education and training program to facilitate the adoption of its innovative technologies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for CREO MEDICAL GROUP PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-12 17:56 |
Director's Dealing
Director/PDMR Share Dealing
|
English | 38.4 KB | |
2025-08-04 08:00 |
Regulatory News Service
Speedboat® patient testimonial
|
English | 13.8 KB | |
2025-07-24 08:00 |
Director's Dealing
Award of Shares under SIP and Director Dealings
|
English | 38.5 KB | |
2025-07-21 08:00 |
Business and Financial Review
H1’25 Trading Update
|
English | 19.8 KB | |
2025-07-10 08:00 |
Regulatory News Service
MicroBlate™ Flex begins lung tumour clinical study
|
English | 14.4 KB | |
2025-07-09 10:41 |
Remuneration Information
PDMR Options Revision
|
English | 11.7 KB | |
2025-06-30 08:00 |
Regulatory News Service
Change of Nominated Adviser
|
English | 11.4 KB | |
2025-06-26 12:08 |
Post-Annual General Meeting Information
Result of AGM
|
English | 12.0 KB | |
2025-06-11 08:00 |
Regulatory News Service
U.S. FDA clearance for SpydrBlade™ Flex
|
English | 17.8 KB | |
2025-06-02 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 22.9 KB | |
2025-05-30 08:00 |
Report Publication Announcement
Posting of AR&R and Notice of AGM
|
English | 14.7 KB | |
2025-05-28 08:00 |
Business and Financial Review
US Reimbursement milestone for Speedboat procedure
|
English | 16.0 KB | |
2025-05-23 17:25 |
Major Shareholding Notification
Holding(s) in Company
|
English | 24.7 KB | |
2025-03-26 08:00 |
Remuneration Information
Grant of Options
|
English | 61.0 KB | |
2025-03-06 08:00 |
Board/Management Information
Appointment of Nominated Adviser and sole Broker
|
English | 11.5 KB |
Automate Your Workflow. Get a real-time feed of all CREO MEDICAL GROUP PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CREO MEDICAL GROUP PLC via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |